Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001104659-24-131728
Filing Date
2024-12-26
Accepted
2024-12-26 16:30:25
Documents
5
Period of Report
2024-12-26

Document Format Files

Seq Description Document Type Size
1 FROM 6-K tm2431898d1_6k.htm 6-K 13889
2 EXHIBIT 99.1 tm2431898d1_ex99-1.htm EX-99.1 36408
3 EXHIBIT 99.2 tm2431898d1_ex99-2.htm EX-99.2 33339
4 GRAPHIC tm2413898d1_ex99-1img001.jpg GRAPHIC 3730
5 GRAPHIC tm2431898d1_ex99-2img001.jpg GRAPHIC 1907
  Complete submission text file 0001104659-24-131728.txt   92777
Mailing Address DR NEERGAARDS VEJ 5F HOERSHOLM G7 2970
Business Address DR NEERGAARDS VEJ 5F HOERSHOLM G7 2970 004531262615
Evaxion Biotech A/S (Filer) CIK: 0001828253 (see all company filings)

EIN.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39950 | Film No.: 241581396
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)